These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8086237)

  • 1. Hypercalcemia and hyperosteolysis in vitamin D intoxication: effects of clodronate therapy.
    Rizzoli R; Stoermann C; Ammann P; Bonjour JP
    Bone; 1994; 15(2):193-8. PubMed ID: 8086237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid effects in vitamin D intoxication.
    Streck WF; Waterhouse C; Haddad JG
    Arch Intern Med; 1979 Sep; 139(9):974-7. PubMed ID: 224830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate.
    Selby PL; Davies M; Marks JS; Mawer EB
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):531-6. PubMed ID: 8548936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication.
    Lee DC; Lee GY
    J Toxicol Clin Toxicol; 1998; 36(7):719-21. PubMed ID: 9865241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of malignant hypercalcaemia with clodronate.
    Percival RC; Paterson AD; Yates AJ; Beard DJ; Douglas DL; Neal FE; Russell RG; Kanis JA
    Br J Cancer; 1985 May; 51(5):665-9. PubMed ID: 3158326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral alendronate therapy for severe vitamin D intoxication of the infant with nephrocalcinosis.
    Atabek ME; Pirgon O; Sert A
    J Pediatr Endocrinol Metab; 2006 Feb; 19(2):169-72. PubMed ID: 16562591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of tumor-induced osteolysis by APD.
    Burckhardt P; Thiébaud D; Perey L; von Fliedner V
    Recent Results Cancer Res; 1989; 116():54-66. PubMed ID: 2762665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of dichloromethylene diphosphonate in metastatic bone disease.
    Jung A; Chantraine A; Donath A; van Ouwenaller C; Turnill D; Mermillod B; Kitler ME
    N Engl J Med; 1983 Jun; 308(25):1499-501. PubMed ID: 6222257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a single infusion of alendronate in malignant hypercalcaemia: dose dependency and comparison with clodronate.
    Rizzoli R; Buchs B; Bonjour JP
    Int J Cancer; 1992 Mar; 50(5):706-12. PubMed ID: 1531972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with clodronate in patients with hypercalcemia secondary to malignancy.
    Lind L; Wengle B; Ljunghall S
    Ups J Med Sci; 1987; 92(3):259-63. PubMed ID: 2966487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.
    Vinholes J; Guo CY; Purohit OP; Eastell R; Coleman RE
    J Clin Oncol; 1997 Jan; 15(1):131-8. PubMed ID: 8996134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clodronate in hypercalcemia of malignancy.
    Bonjour JP; Rizzoli R
    Calcif Tissue Int; 1990; 46 Suppl():S20-5. PubMed ID: 2137362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevations in serum and urinary calcium with parathyroid hormone (1-84) with and without alendronate for osteoporosis.
    Antoniucci DM; Sellmeyer DE; Bilezikian JP; Palermo L; Ensrud KE; Greenspan SL; Black DM
    J Clin Endocrinol Metab; 2007 Mar; 92(3):942-7. PubMed ID: 17164314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypercalcaemia of malignancy with clodronate.
    Bonjour JP; Rizzoli R
    Bone; 1991; 12 Suppl 1():S19-23. PubMed ID: 1835397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of clodronate in multiple myeloma.
    Delmas PD
    Bone; 1991; 12 Suppl 1():S31-4. PubMed ID: 1835398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pamidronate treatment in acute vitamin D intoxication.
    Gurkan F; Davutoglu M; Bosnak M; Ece A; Dikici B; Bilici M; Haspolat K
    J Endocrinol Invest; 2004; 27(7):680-2. PubMed ID: 15505994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [[Clodronate therapy of hypercalcemia caused by hyperparathyroidism].
    Hoffmeyer P; Groebli Y; Spiliopoulos A; Jung A
    Schweiz Med Wochenschr; 1982 Jan; 112(4):118-20. PubMed ID: 6461066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug-induced hypercalcemia].
    Sato K
    Clin Calcium; 2006 Jan; 16(1):67-72. PubMed ID: 16397353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral clodronate therapy for hypercalcemia related to extensive subcutaneous fat necrosis in a newborn.
    Hung SH; Tsai WY; Tsao PN; Chou HC; Hsieh WS
    J Formos Med Assoc; 2003 Nov; 102(11):801-4. PubMed ID: 14724728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia.
    Body JJ; Delmas PD
    J Clin Endocrinol Metab; 1992 Mar; 74(3):471-5. PubMed ID: 1740478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.